BRD-K43164817-001-01-9 (Substance)

Compound:

N'-(2-aminophenyl)-N-[(2S,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

Compound (Entity type)

Synonyms:BRD-K43164817-001-01-9

Id:85813823

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View BRD-K43164817-001-01-9's neighborhood in the knowledge graph.

Submit

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 PBIOA009 XC.L10 24H I01 BRD-K43164817 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 PBIOA009 XC.R10 24H I03 BRD-K43164817 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 PBIOA009 XC.L10 24H I02 BRD-K43164817 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 PBIOA009 XC.L10 24H I03 BRD-K43164817 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 PBIOA009 XC.R10 24H I01 BRD-K43164817 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 PBIOA009 XC.R10 24H I02 BRD-K43164817 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project